|
|
The Protégé Encore and Protégé studies have closed and are no longer enrolling patients.
What is the Protégé study?
The Protégé study will further evaluate the safety of teplizumab and test whether it will reduce or prevent the autoimmune attack that damages beta cells.Who can join the Protégé study?
To be in the Protégé study, you must:
- Be 8 to 35 years of age
- Have had your first visit to a doctor for symptoms of type 1 diabetes and received that diagnosis within 12 weeks of starting treatment on this study
- Weigh at least 36 kg (79 lbs)
- Not be using any other experimental treatment during the time you are in the study
- Not have received treatment with a monoclonal antibody within 1 year before joining the study
- Not currently be using or planning to use inhaled insulin
- Not have received a vaccination with a live virus within 12 weeks before joining the study
How do I get more information?
The Protégé Encore and Protégé studies have closed and are no longer enrolling patients.February 19, 2008
|
|
|||
Last Updated: Monday December 13, 2010 17:23:38
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.